Update on the pathophysiology and medical treatment of peripheral artery disease
J Golledge - Nature Reviews Cardiology, 2022 - nature.com
Approximately 6% of adults worldwide have atherosclerosis and thrombosis of the lower
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …
[HTML][HTML] In vitro and in vivo characterization methods for evaluation of modern wound dressings
N Ahmad - Pharmaceutics, 2022 - mdpi.com
Chronic wound management represents a major challenge in the healthcare sector owing to
its delayed wound-healing process progression and huge financial burden. In this regard …
its delayed wound-healing process progression and huge financial burden. In this regard …
A regenerative approach to the pharmacological management of hard-to-heal wounds
M van de Vyver, PJ Idensohn, CU Niesler - Biochimie, 2022 - Elsevier
A wound is considered hard-to-heal when, despite the appropriate clinical analysis and
intervention, the wound area reduces by less than a third at four weeks and complete …
intervention, the wound area reduces by less than a third at four weeks and complete …
Association between homocysteine level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study
X Wang, Y Yang, L Xu, L Yu, S Zang, X Li - BMJ open, 2023 - bmjopen.bmj.com
Objectives Homocysteine (Hcy) level has been widely identified as a risk factor associated
with adverse outcomes in patients with lower extremity atherosclerotic disease (LEAD) …
with adverse outcomes in patients with lower extremity atherosclerotic disease (LEAD) …
[HTML][HTML] Advances in neovascularization after diabetic ischemia
Y Cai, GY Zang, Y Huang, Z Sun, LL Zhang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
With the high incidence of diabetes around the world, ischemic complications cause a
serious influence on people's production and living. Neovascularization plays a significant …
serious influence on people's production and living. Neovascularization plays a significant …
各种组学分析在体表慢性难愈合创面中的研究进展
曾帅丹, 杨磊 - 中华烧伤与创面修复杂志, 2023 - zhsszz.xml-journal.net
体表慢性难愈合创面的诊断和治疗一直充满着挑战, 对医疗和社会造成巨大负担.
利用高通量测序技术结合组学分析可以揭示慢性创面形成的潜在机制, 识别与慢性创面诊断 …
利用高通量测序技术结合组学分析可以揭示慢性创面形成的潜在机制, 识别与慢性创面诊断 …
Reversion of the Inflammatory Markers in Patients With Chronic Limb‐Threatening Ischemia
J Ferreira, S Roque, A Lima Carneiro… - Journal of the …, 2024 - Am Heart Assoc
Background Peripheral artery disease is characterized by an intense inflammatory process
that can be associated with a higher mortality rate, particularly in chronic limb‐threatening …
that can be associated with a higher mortality rate, particularly in chronic limb‐threatening …
Natural antioxidant in cardiovascular and cerebrovascular diseases
YS Jung - Antioxidants, 2022 - mdpi.com
Cardiovascular (CVD) and cerebrovascular diseases, with 17.9 million and 2 million deaths
every year, respectively, are the leading cause of death worldwide [1, 2]. The accumulation …
every year, respectively, are the leading cause of death worldwide [1, 2]. The accumulation …
CNPY2 governs PDGF‑BB‑treated vascular smooth muscle cell proliferation, migration and phenotypic transformation via the Akt/mTOR/GSK‑3β signaling pathway
H Sun, X Wang, L Ma, X Li… - Experimental and …, 2024 - spandidos-publications.com
Phenotype switching of vascular smooth muscle cells (VSMCs) is a pathological process in
various vascular diseases. Canopy FGF signaling regulator 2 (CNPY2) has previously been …
various vascular diseases. Canopy FGF signaling regulator 2 (CNPY2) has previously been …
Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway
W Sun, L Zhang, Z Fang, L Han, Q Wang… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Shuxuetong (SXT) injection is formulated by leech and
earthworm, has been widely used in the treatment of thrombotic cardiovascular and …
earthworm, has been widely used in the treatment of thrombotic cardiovascular and …